Psychiatric safety of ketamine in psychopharmacology research

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Psychopharmacology

• Publication date

  2007-02-16

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-007-0706-2PMID 17458544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Selective Cognitive Impairments Associated with NMDA Receptor Blockade in Humans

  2005cited by this paper
• Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study.

  2005cited by this paper
• Miller's Anesthesia

  2005cited by this paper
• Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.

  2005cited by this paper
• Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

  2005cited by this paper
• Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine

  2005cited by this paper
• the Effect of

  2004influential reference
• Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.

  2004influential reference
• Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

  2004cited by this paper
• Altered NMDA Glutamate Receptor Antagonist Response in Recovering Ethanol-Dependent Patients

  2003influential reference
• Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study

  2003cited by this paper
• Patterns of use and harms associated with non-medical ketamine use.

  2003cited by this paper
• NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

  2003influential reference
• NMDA Receptor Antagonism and the Ethanol Intoxication Signal

  2003influential reference
• Effects of Ketamine in Normal and Schizophrenic Volunteers

  2001cited by this paper
• Long-term outcome of patients who receive ketamine during research.

  2001cited by this paper
• Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.

  2000cited by this paper
• Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders.

  1999influential reference
• The schizophrenia ketamine challenge study debate.

  1999cited by this paper
• Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia.

  1999cited by this paper
• Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

  1999influential reference
• Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

  1999cited by this paper
• Therapeutic Implications of the Hyperglutamatergic Effects of NMDA Antagonists

  1999influential reference
• NMDA-Sensitive Glutamate Antagonism: A Human Model for Psychosis

  1999cited by this paper
• The NMDA antagonist model for schizophrenia: promise and pitfalls.

  1998cited by this paper
• Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics.

  1998influential reference
• Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

  1998cited by this paper
• Glycine ketamine interactions in healthy humans

  1997cited by this paper
• NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

  1996cited by this paper
• Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

  1995cited by this paper
• Glutamate receptor dysfunction and schizophrenia.

  1995cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994influential reference
• Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia.

  1992cited by this paper
• Ketamine: an update on the first twenty-five years of clinical experience

  1989cited by this paper
• An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?

  1985cited by this paper
• Comparison of Ketamine and Thiopental in Healthy Volunteers: Effects on Mental Status, Mood, and Personality

  1984cited by this paper
• Reliabilities and intercorrelations of eight measures of proneness to psychosis.

  1982cited by this paper
• Computerized Evaluation of Psychic Effects of Ketamine

  1971cited by this paper

• Promising experimental drugs for obsessive-compulsive personality disorder

  2025cites this paper
• Effects of Ketamine and Esketamine on Cognitive Functions in Treatment-Resistant Depression

  2024cites this paper
• Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung

  2024cites this paper
• Intravenous ketamine for emergency department treatment of suicidal ideation in a paediatric population: protocol for a double-blind, randomised, placebo-controlled, parallel-arm pilot trial (KSI study)

  2024cites this paper
• Blood pressure changes during ketamine infusion for the treatment of depression.

  2024cites this paper
• Intraoperative Low-Dose S-Ketamine Reduces Depressive Symptoms in Patients with Crohn’s Disease Undergoing Bowel Resection: A Randomized Controlled Trial

  2023cites this paper
• Premature commitment to uncertain decisions during human NMDA receptor hypofunction

  2022cites this paper
• A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression

  2022cites this paper
• Optimized Clinical Strategies for Treatment-Resistant Depression: Integrating Ketamine Protocols with Trauma- and Attachment-Informed Psychotherapy

  2022cites this paper
• Premature commitment to uncertain decisions during human NMDA receptor hypofunction

  2022cites this paper
• Psychedelics in the treatment of unipolar and bipolar depression

  2022cites this paper
• A Novel Application of Ketamine for Improving Perioperative Sleep Disturbances

  2021cites this paper
• Ketamine in the treatment of cocaine use disorders

  2021cites this paper
• Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla

  2021cites this paper
• NSS_A_341161 2251..2266

  2021cites this paper
• Ketamine in Psychiatric Disorders

  2021cites this paper
• Ketamine Alleviates Depressive Symptoms in Patients Undergoing Intracranial Tumor Resection: A Randomized Controlled Trial

  2021cites this paper
• Acute Effects of Ketamine Infusion on Postoperative Mood Scores in Patients Undergoing Dilation and Curettage: A Randomized Double-Blind Controlled Study

  2021cites this paper
• Off‐Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk‐Benefit Profile

  2021cites this paper
• The next psychoactive drugs: From imipramine to ketamine

  2020cites this paper
• Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy

  2020cites this paper
• Cognition in mood disorders

  2020cites this paper
• Cognitive research on addiction in a changing policy landscape

  2020cites this paper
• Therapeutic Mechanisms of Ketamine.

  2020cites this paper
• Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study

  2020cites this paper
• Ketamine for Acute Pain Management and Sedation.

  2020cites this paper
• Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers

  2020cites this paper
• Psychotropes du futur : de l’imipramine à la kétamine

  2020cites this paper
• Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study

  2020cites this paper
• Premature commitment to uncertain beliefs during human NMDA receptor hypofunction

  2020cites this paper
• Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia

  2020cites this paper
• Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder

  2019cites this paper
• Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder.

  2019cites this paper
• Effects of ketamine treatment on cocaine-induced reinstatement and disruption of functional connectivity in unanesthetized rhesus monkeys

  2019cites this paper
• Post-traumatic stress disorder or emergence phenomena? A case of psychomotor agitation after procedural sedation and analgesia

  2019cites this paper
• Experimental Medicine Approaches in CNS Drug Development

  2019cites this paper
• Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study

  2018cites this paper
• A sub‐set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study

  2018cites this paper
• Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study

  2018cites this paper
• Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder

  2018cites this paper
• Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects.

  2018cites this paper
• Ketamine Use for Suicidal Ideation in the General Hospital: Case Report and Short Review

  2018cites this paper
• Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trial

  2018cites this paper
• Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.

  2018cites this paper
• Hallucinogen Persisting Perception Disorder Following Therapeutic Ketamine: A Case Report

  2017cites this paper
• Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

  2017cites this paper
• Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial

  2017cites this paper
• Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia.

  2017cites this paper
• Oral Ketamine in Treatment-Resistant Depression

  2017cites this paper
• Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats.

  2017cites this paper
• Using transcranial direct-current stimulation (tDCS) to understand cognitive processing

  2017cites this paper
• Ketamine Has Distinct Electrophysiological and Behavioral Effects in Depressed and Healthy Subjects

  2017cites this paper
• Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.

  2017cites this paper
• A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

  2017cites this paper
• Oral Ketamine in Treatment-Resistant Depression A Clinical Effectiveness Case Series

  2017cites this paper
• Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242

  2017cites this paper
• Ketamine alone or combined with midazolam or dexmedetomidine does not affect anxiety-like behaviours and memory in adult Wistar rats

  2017cites this paper
• Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography

  2017cites this paper
• Ketamine and electroconvulsive therapy pairing in depression and mood disorders

  2017cites this paper
• La découverte des propriétés antidépressives de la kétamine

  2017cites this paper
• Has psychiatry tamed the "ketamine tiger?" Considerations on its use for depression and anxiety.

  2016cites this paper
• Ketamine for Treatment-Resistant Unipolar Depression: Current Evidence

  2016cites this paper
• Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study

  2016cites this paper
• Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

  2016cites this paper
• Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

  2016cites this paper
• Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice

  2016cites this paper
• Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial)

  2016cites this paper
• An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.

  2016cites this paper
• Ketamine—A Narrative Review of Its Uses in Medicine

  2016cites this paper
• Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

  2016influential citation
• Ketamine Usage at Subanesthetic Doses and Psychoactive Effects

  2016cites this paper
• Optimizing the glutamatergic challenge model for psychosis, using S(+)-ketamine to induce psychomimetic symptoms in healthy volunteers

  2015cites this paper
• The use of ketamine as an antidepressant: a systematic review and meta‐analysis

  2015cites this paper
• Repeated ketamine administration alters N-methyl-d-aspartic acid receptor subunit gene expression: Implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans

  2015cites this paper
• Role of Ketamine in Acute Postoperative Pain Management: A Narrative Review

  2015cites this paper
• Ketamine uropathy: Hong Kong experience

  2015cites this paper
• Ketamin: Yeni Bir Antidepresan? Ketamine: A New Antidepressant?

  2015cites this paper
• Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects

  2015cites this paper
• Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

  2015cites this paper
• Ketamine safety and tolerability in clinical trials for treatment-resistant depression.

  2015cites this paper
• The antidepressant effects of ketamine and the underlying mechanisms

  2015cites this paper
• Ketamine Infusion in Treatment Resistant Depression: A Case Report and Brief Review of The Literature

  2015cites this paper
• Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

  2015cites this paper
• Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

  2015cites this paper
• Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial

  2015cites this paper
• Ketamine-Induced Hallucinations

  2015cites this paper
• The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment

  2014cites this paper
• Electrophysiological Investigations of the Effects of a Subanesthetic Dose of Ketamine on Monoamine Systems.

  2014cites this paper
• Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression.

  2014cites this paper
• Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

  2014cites this paper
• Ketamin als Antidepressivum

  2014cites this paper
• Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response

  2014cites this paper
• A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

  2014cites this paper
• Therapeutic infusions of ketamine: do the psychoactive effects matter?

  2014influential citation
• The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers.

  2014cites this paper
• Ketamin als Antidepressivum

  2014cites this paper
• Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

  2014cites this paper
• Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions

  2013influential citation
• The contribution of the brain response to ketamine to understanding the glutamatergic system and its role in human cognition

  2013cites this paper
• Évaluer l’efficacité de l’association d’une injection de kétamine et de la venlafaxine dans l’épisode dépressif majeur sévère durant six semaines : « KETADEP »

  2013cites this paper